🇺🇸 FDA

Intelligence Platform

Patents

Browse 121 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10501444

Inhibitors of influenza virus replication, application methods and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494364

Cathepsin K inhibitors and application thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434131

Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, di

Nature's Sunshine Products, Inc. · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10370380

Octahydropyrrolo[3,4-c]pyrrole derivatives and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10316025

Substituted piperazine compounds and methods of use and use thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10308658

Salt of EGFR inhibitor, crystalline form and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266521

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266496

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses the

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196383

Substituted quinazoline compounds and preparation and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183917

Tricyclic compounds and uses thereof in medicine

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179155

Phosphodiesterase-4 inhibiting phytochemical compositions

Nature's Sunshine Products, Inc. · Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149841

Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof

Shenyang Sunshine Pharmaceutical Co., LTD · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10098889

Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceutic

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10100051

Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparat

Shenyang Sunshine Pharmaceutical Co., LTD · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10065928

Quinolinone compound and use thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10065934

Substituted urea derivatives and pharmaceutical uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10059689

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9994566

Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation me

Shenyang Sunshine Pharmaceutical Co., LTD · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974785

Aromatic heterocyclic derivatives and pharmaceutical applications thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9951010

Compounds as CRTH2 antagonist and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938257

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9926324

Heteroaromatic compounds as PI3 kinase modulators and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9920033

Crystalline form of a substituted quinoline compound and pharmaceutical compositions there

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9902712

Nitrogenous heterocyclic derivatives and their application in drugs

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted